Drug intelligence / Profile preview

shenguo laonian ganmao granules

Development stage: Unknown
Lead developer: Shaanxi Tianfang Technology
Modality: Small Molecules
Administration: Oral

Overview

Shenguo Laonian Ganmao Granules is a Traditional Chinese Medicine (TCM) formulation developed by Shaanxi Tianfang Technology Co., Ltd. specifically for the treatment of the common cold and acute upper respiratory tract infections in middle-aged and elderly patients. As a TCM product, it is composed of multiple herbal extracts designed to alleviate symptoms such as fever, cough, and fatigue while accounting for the specific physiological characteristics and vulnerabilities of the elderly population. The drug has been evaluated in clinical trials in China (e.g., CTR20140146) to establish its safety and therapeutic efficacy in this demographic.

Brand names: Shenguo Laonian Ganmao Granules
Other names: 参果老年感冒颗粒

Beyond the preview

Go deeper on shenguo laonian ganmao granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenguo laonian ganmao granules.

Explore the full profile